Stephen Reece

Stephen Reece has an extensive work experience in the biotechnology and research industry. Stephen currently serves as the Head of IDV at Kymab Ltd since November 2022. Prior to this, they held the position of Director, Antimicrobial Antibodies and Vaccines at Kymab Ltd from January 2021 to November 2022. Before joining Kymab Ltd, Stephen worked as a Group Leader, Infectious Diseases and Vaccines at the same company from October 2017 to January 2021.

Stephen's previous roles include Project Manager-Infectious Diseases at Cambridge University from June 2016 to September 2017, and Project Manager at the Centre for Genomic Pathogen Surveillance at Wellcome Trust Sanger Institute from April 2015 to February 2016.

Stephen also held positions at BioNTech AG as a Senior Project Manager from August 2013 to March 2015, as the Head of Vaccines at CureVac GmbH from December 2012 to May 2013, and as a Senior Researcher/Team Leader at Max Planck Institute for Infection Biology from March 2006 to December 2012.

Stephen's earlier experience includes roles at Infectious Disease Research Institute as a Scientist I from January 2005 to February 2006, and as a Postdoctoral Fellow from July 2002 to January 2005. Stephen began their career at HKUST as a Research Assistant from February 1995 to September 1997 and worked as a Microbiologist at Genzyme from December 1993 to February 1995.

Stephen Reece earned a Bachelor's degree in Biochemistry from Imperial College London from 1990 to 1993. Stephen later pursued a Master's degree in Infectious Diseases from the London School of Hygiene and Tropical Medicine, U. of London, from 1997 to 1998. Finally, they obtained a Doctor of Philosophy (PhD) in Molecular Biology from Imperial College London from 1998 to 2002.